GAFA
TRLV

Garton & Associates Financial Advisors’s Trulieve Cannabis Corp TRLV Stock Holding History

Garton & Associates Financial Advisors’s Portfolio TRLV Stock Details TRLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20
Closed -$174 – 753
2025
Q4 		$174 Buy
+20
New +$174 ﹤0.01% 1158

Other funds holding TRLV

NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
ADMI
Albert D. Mason Inc Boston, Massachusetts $154M AUM 25.1% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
HC
Hurley Capital New York $187M AUM 23.24% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return

Garton & Associates Financial Advisors's TRLV Position: Q1 2026 in Review

Garton & Associates Financial Advisors sold out of Trulieve Cannabis Corp (TRLV) in Q1 2026, closing a stake of 20 shares — an estimated $174 sold.

Garton & Associates Financial Advisors first reported a position in TRLV in Q4 2025 and held it in 1 quarter. The position peaked at $174 in Q4 2025. 6 funds tracked by Wall St. Rank hold TRLV as of Q1 2026.

  • Garton & Associates Financial Advisors reported no remaining Trulieve Cannabis Corp position as of Q1 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 20 Trulieve Cannabis Corp shares in Q1 2026, an estimated $174.
  • Garton & Associates Financial Advisors first reported a position in Trulieve Cannabis Corp in Q4 2025 and held it in 1 quarter.
  • Garton & Associates Financial Advisors's Trulieve Cannabis Corp position peaked at $174 in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Trulieve Cannabis Corp as of Q1 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.